Clinical trial
Smoking-induced EGF-dependent Reprogramming of Airway Basal Cell Function
NCT01974180 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Smoking-induced EGF-dependent Reprogramming of Airway Basal Cell Function
- Lead sponsor
- Weill Medical College of Cornell University
- Phase
- Observational
- Overall status
- Terminated
- Start date
- December 3, 2013
- Completion date
- April 23, 2015
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease, copd, smoking